Short description
Ring Therapeutics is a gene therapy company focused on discovering and developing programmable genetic medicines.
Description
Ring Therapeutics is a multi-product platform company focused on discovering and developing Anellovector therapeutics to unlock the full potential of gene therapy. Founded by Flagship Pioneering, Ring is pioneering the first redosable and targetable gene therapy platform by harnessing the biology of the human commensal virome. The company is expanding the applications of gene therapy beyond gene replacement, enabling a much wider array of modalities and mechanisms to treat previously inaccessible diseases.
Last funding
No Way
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Cambridge, Massachusetts, United States, North America
Founded on
January 1, 2017
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$7890 - 12340
Sign in for full access
Investors
Noaccess, Cannot Access, Nopepepe, Cannot Access, Nopepepe, Noway Youcantaccess, Cannot Access, Nopepepe, Nopepepe
Sign in for full access
Founders
Avak Kahvejian, Erica Weinstein, Noubar Afeyan